October 23, 2020

Diabetic retinopathy is a major cause of blindness in the United States.  Diabetic macular edema is the primary cause of vision loss associated with diabetic retinopathy.    Studies show that patients of color have a higher risk of diabetic macular edema associated with diabetes, obesity, and hypertension being comorbidities. The Los Angeles Latino Eye Study...

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 19 to 23, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. FDA Needs More Safety...

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 19 to 23, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. FDA Needs More Safety...

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 19 to 23, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. FDA Needs More Safety...

FRIDAY, Oct. 23, 2020 (HealthDay News) — At a meeting of the U.S. Food and Drug Administration vaccine advisory board, some experts warned that the guidelines requiring two months of safety data after a volunteer has been vaccinated were not enough, TheNew York Timesreported Thursday. The stakes are very high, experts said. A vaccine is...

FRIDAY, Oct. 23, 2020 (HealthDay News) — When a COVID-19 vaccine becomes available, the U.S. Centers for Disease Control and Prevention will monitor those taking the vaccine for any health problems via text messages and online surveys,CNNreported Thursday. “V-SAFE is a new smartphone-based active surveillance program for COVID-19,” Tom Shimabukuro, M.D., deputy director of the...

FRIDAY, Oct. 23, 2020 (HealthDay News) — For patients with moderate COVID-19, convalescent plasma does not reduce progression to severe COVID-19 or mortality, according to a study published online Oct. 22 in The BMJ. Anup Agarwal, M.B.B.S., from the Indian Council of Medical Research in New Delhi, and colleagues conducted an open-label, parallel arm, phase...

FRIDAY, Oct. 23, 2020 (HealthDay News) — For patients with psoriasis, survival from COVID-19 is high, with increased hospitalization risk in association with nonbiologic systemic therapy versus biologic use, according to a study published online Oct. 16 in the Journal of Allergy and Clinical Immunology. Satveer K. Mahil, M.D., Ph.D., from Guy’s and St. Thomas’...

FRIDAY, Oct. 23, 2020 (HealthDay News) — Tocilizumab may be beneficial for adults with COVID-19 admitted to the intensive care unit (ICU), although other findings are conflicting, according to three studies and an editorial published online Oct. 20 in JAMA Internal Medicine. Shruti Gupta, M.D., M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues...